Menu
Back to Journals » OncoTargets and Therapy » Volume 15
Corrigendum
RANKL/RANK Pathway Abrogates Cetuximab Sensitivity in Gastric Cancer Cells via Activation of EGFR and c-Src [Corrigendum]
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,227 | Dovepress* | 4,191+ | 260 | 4,451 | |
| PubMed Central* | 36 | 25 | 61 | ||
| Totals | 4,227 | 285 | 4,512 | ||
| *Since 13 May 2022 | |||||
View citations on PubMed and Google Scholar